Personalkatalog
Sök |
|
Lista institutioner och enheter i
Institutioner och enheter i bokstavsordning |
Parviz Behnam Motlagh
Kontaktinformation |
|
|
|
Befattning: |
Forskningsingenjör, förste |
|
|
Verksam vid: |
||
|
Avdelning: |
||
|
Adress: |
Umeå universitet |
|
|
Besöksadress: |
By 6M, vån 2, Sjukhusområdet |
|
|
Tel: |
+46 90 785 29 81 |
|
|
Fax: |
+46 90 785 44 84 |
|
|
E-postadress: |
||
|
Webbsida: |
http://www.medbio.umu.se/om-institutionen/personal/behnam-motlagh-parviz/
Webbsida |
|
Publikationer
Michels, Judith |
Cisplatin Resistance Associated with PARP Hyperactivation
|
2013 |
- |
Galluzzi, Lorenzo |
Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer
|
2012 |
- |
Behnam-Mothlag, Parviz |
2012 |
||
Tyler, Anders |
2011 |
- |
|
Behnam Motlagh, Parviz |
2011 |
- |
|
Johansson, David |
Cisplatin-induced expression of Gb3 enables verotoxin-1 treatment of cisplatin resistance in malignant pleural mesothelioma cells
|
2010 |
- |
Behnam-Motlagh, Parviz |
Verotoxin-1 Treatment or Manipulation of its Receptor Globotriaosylceramide (Gb3) for Reversal of Multidrug Resistance to Cancer Chemotherapy
|
2010 |
|
Johansson, David |
Expression of verotoxin-1 receptor Gb3 in breast cancer tissue and verotoxin-1 signal transduction to apoptosis: Bacterial toxins, cancer treatment
|
2009 |
- |
Janson, Veronica |
Phase-contrast microscopy studies of early Cisplatin-induced morphological changes of malignant mesothelioma cells and the correspondence to induced apoptosis.
|
2008 |
- |
Johansson, David |
alpha-Toxin of Staphylococcus aureus overcomes acquired cisplatin-resistance in malignant mesothelioma cells.
|
2008 |
- |






